skip to the content

MabThera and Rheumatoid Arthritis

MabThera, the first and only selective B cell therapy for rheumatoid arthritis (RA), represents an innovative treatment option for RA patients and offers lasting treatment success.

MabThera, in combination with methotrexate, is indicated for the treatment of adult patients with severe, active RA who have had an inadequate response or intolerance to current treatment options, including one or more TNF inhibitors.